Dr. Krishna Bilas Ghimire, MD

Dr. Ghimire practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Ghimire's NPI, 1225340359, was assigned on July 6, 2010. Dr. Ghimire graduated from University of Illinois College of Medicine at Chicago in 2010. Dr. Ghimire holds New York license 299580.

Dr. Ghimire's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Ghimire's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Ghimire is also affiliated with Wynn Hospital. The medical group on file is Department of Medicine. Dmand AI also links Dr. Ghimire to 1 more hospital, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghimire practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ghimire's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ghimire is licensed in New York.

CMS data shows 654 Medicare services from Dr. Ghimire across 6 procedure codes in 2024, for 250 Medicare patients. Medicare paid $50,653 for them.

CMS counts 250 Medicare patients who saw Dr. Ghimire in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghimire's median patient age at 64, with 50% women.

In 2024, Dr. Ghimire wrote 284 Medicare Part D claims for 80 patients. 79% of them were for generic drugs. CMS names the drug for 130 of them, across 9 drugs with 11 or more claims each, at $8,191 in total drug cost. In 2023, CMS named 102 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ghimire for performance year 2024, reported as part of a group. Dr. Ghimire accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghimire as offering telehealth.

Dmand AI links 13 papers to Dr. Ghimire, published from 2013 to 2023. 2014 was the busiest year, with 4. The most frequent topics are SEER Program, Leukemia, Myeloid, Acute and Hematopoietic Stem Cell Transplantation. Dr. Ghimire has published most often in Acta Oncol. Dr. Ghimire's most frequent co-authors are Binay Kumar Shah, MD, Seah Hooi Lim, MD and Prashanth Ashok Kumar.

CMS Open Payments shows 12 general payments to Dr. Ghimire from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Celgene Corporation paid the most, $134.

Dr. Ghimire graduated from University of Illinois College of Medicine at Chicago in 2010.